CONTIN, MANUELA MARIA ANTONIA
 Distribuzione geografica
Continente #
NA - Nord America 2.915
EU - Europa 2.008
AS - Asia 654
AF - Africa 117
SA - Sud America 10
OC - Oceania 4
Totale 5.708
Nazione #
US - Stati Uniti d'America 2.908
GB - Regno Unito 481
IT - Italia 448
DE - Germania 282
SE - Svezia 278
CN - Cina 189
SG - Singapore 154
IN - India 120
UA - Ucraina 119
VN - Vietnam 114
IE - Irlanda 100
RU - Federazione Russa 75
FR - Francia 64
TG - Togo 41
JO - Giordania 36
EE - Estonia 35
BG - Bulgaria 32
ZA - Sudafrica 32
CI - Costa d'Avorio 28
CH - Svizzera 27
FI - Finlandia 19
BE - Belgio 15
HK - Hong Kong 12
SC - Seychelles 10
NL - Olanda 8
BR - Brasile 6
CA - Canada 6
ES - Italia 6
UZ - Uzbekistan 6
JP - Giappone 5
TR - Turchia 5
NG - Nigeria 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
HR - Croazia 3
AT - Austria 2
AU - Australia 2
CL - Cile 2
IR - Iran 2
IS - Islanda 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PL - Polonia 2
RO - Romania 2
TH - Thailandia 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 5.708
Città #
Southend 426
Chandler 333
Ann Arbor 318
Fairfield 310
Ashburn 220
Houston 173
Woodbridge 158
Seattle 137
Singapore 132
Wilmington 124
Cambridge 114
Bologna 113
Princeton 113
Dublin 100
Jacksonville 77
Redmond 48
Westminster 43
Lomé 41
Amman 36
Nanjing 36
Padova 36
Berlin 32
Sofia 31
Turin 30
Abidjan 28
Florence 27
Dong Ket 24
Santa Clara 24
Bern 23
Milan 21
Saint Petersburg 21
Bremen 20
Frankfurt am Main 20
Helsinki 19
Jinan 18
Dearborn 17
New York 17
San Diego 16
Shenyang 15
Brussels 14
Los Angeles 13
Medford 12
Jiaxing 11
Mülheim 11
Changsha 10
Des Moines 10
Hong Kong 10
Redwood City 10
Beijing 9
Hebei 9
Mahé 9
Rome 9
Tianjin 9
Cesena 8
Hangzhou 8
Pune 8
Kuban 7
Nanchang 7
Boardman 6
Falls Church 6
Olalla 6
Taiyuan 6
Toronto 6
Bühl 5
Haikou 5
Livorno 5
Ningbo 5
Norwalk 5
Sannicandro di Bari 5
Verona 5
Washington 5
Zhengzhou 5
Botticino 4
Hefei 4
Kunming 4
Paris 4
San Francisco 4
São Paulo 4
Tokyo 4
Abeokuta 3
Boydton 3
Dubai 3
Fuzhou 3
Guangzhou 3
Lanzhou 3
London 3
Modena 3
Noicattaro 3
Ravenna 3
Trento 3
Wuhan 3
Argelato 2
Bangkok 2
Bentivoglio 2
Brooklyn 2
Ceto 2
Chicago 2
Costa Mesa 2
Forlimpopoli 2
Hyderabad 2
Totale 3.832
Nome #
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 214
Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy 206
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. 190
Apparecchiatura per l'esecuzione di test psicomotori. 170
Supervised versus unsupervised technology-based levodopa monitoring in Parkinson’s disease: an intrasubject comparison 160
DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism 153
The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease. 148
Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease 148
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 142
Mathematical modeling and parameter estimation of levodopa motor response in patients with Parkinson disease 142
A mathematical model of levodopa medication effect on basal ganglia in parkinson’s disease: An application to the alternate finger tapping task 141
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 139
Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy. 134
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy 127
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. 126
Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepiness. 123
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy 121
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 120
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. 116
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia 116
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship 116
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias. 110
Liver transplant reverses biochemical imbalance in mitochondrial neurogastrointestinal encephalomyopathy 109
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease. 107
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy 106
Assessing dopaminergic function in early onset Parkinson's disease linked to homozygous PINK1 mutation. 104
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. 103
Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? 103
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. 100
CPAP treatment lowers sympathetic nerve activity and blood pressure in hypertensive obstructive sleep apnoea patients. 97
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 96
Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications 95
Iodine-123-meta-iodobenzylguanidine myocardial scintigraphy in isolated autonomic failure: Potential red flag for future multiple system atrophy 94
Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson’s disease 94
Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 93
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 92
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 91
Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations 90
HPLC-UV analysis of thymidine and deoxyuridine in plasma of patients with thymidine phosphorylase deficiency 90
Il trattamento con CPAP riduce l'attività simpatica e la pressione arteriosa in pazienti con Sindrome delle Apnee Ostruttive nel Sonno ed ipertensione. 86
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. 83
Polisomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome. 76
Il monitoraggio terapeutico dei farmaci antiepilettici 76
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 74
Development and validation of volumetric absorptive microsampling coupled with UHPLC-MS/MS for the analysis of gamma-hydroxybutyric acid in human blood 65
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 54
Il monitoraggio terapeutico dei farmaci in neurologia 50
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list 47
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset 46
TYMP Variants Result in Late-Onset Mitochondrial Myopathy With Altered Muscle Mitochondrial DNA Homeostasis 41
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome 38
Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic Monitoring 36
Autonomic failure in a case of Chiari malformation type I 30
Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey 30
Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors 29
A rapid and simple uhplc-ms/ms method for quantification of plasma globotriaosylsphingosine (Lyso-gb3) 29
Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort 29
TELEmedicine for EPIlepsy Care (TELE-EPIC): Protocol of a randomised, open controlled non-inferiority clinical trial 27
Autonomic nervous system function in myotonic dystrophy 21
Volumetric absorptive microsampling coupled with UHPLC-MS/MS for the determination of Lyso-Gb3 as Fabry disease diagnostic biomarker 16
Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam 14
Isolated failure of noradrenergic transmission in a case with orthostatic hypotension and hyperactivity of gastro-colic reflex 14
Cerebrospinal Fluid Concentrations of Nimodipine Correlate With Long-term Outcome in Aneurysmal Subarachnoid Hemorrhage: Pilot Study 9
Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone 9
Severe dysautonomic onset of Guillain-Barré syndrome with good recovery. A clinical and autonomic follow-up study 1
Totale 5.856
Categoria #
all - tutte 15.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.091 0 0 40 73 109 137 159 173 195 80 67 58
2020/2021774 146 53 27 36 65 56 15 47 66 34 47 182
2021/20221.288 61 35 95 92 104 70 40 100 82 123 255 231
2022/20231.335 140 198 72 152 81 98 50 75 241 25 131 72
2023/2024431 23 66 32 41 42 89 24 21 28 25 10 30
2024/2025276 65 186 25 0 0 0 0 0 0 0 0 0
Totale 5.856